AGF Management’s AstraZeneca AZN Stock Holding History

AGF Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$263K	Sell	1,387 -235	-14%	-$44.2K	﹤0.01%	647
2026 Q1	$320K	Sell	1,622 -1	-0.1%	-$193	﹤0.01%	618
2025 Q4	$298K	Hold	1,623	–	–	﹤0.01%	628
2025 Q3	$249K	Hold	1,623	–	–	﹤0.01%	635
2025 Q2	$227K	Hold	1,623	–	–	﹤0.01%	616
2025 Q1	$239K	Hold	1,623	–	–	﹤0.01%	642
2024 Q4	$213K	Sell	1,623 -668,435	-100%	-$93.6M	﹤0.01%	677
2024 Q3	$104M	Buy	670,058 +18,278	+3%	+$2.95M	0.53%	58
2024 Q2	$102M	Buy	651,780 +253,233	+64%	+$38.1M	0.56%	57
2024 Q1	$54M	Buy	398,547 +32	+0%	+$4.24K	0.3%	103
2023 Q4	$53.7M	Buy	398,515 +5,709	+1%	+$742K	0.32%	103
2023 Q3	$53.2M	Buy	+392,806	New	+$53.6M	0.38%	94
2023 Q2	–	Sell	-712,954	Closed	-$99M	–	681
2023 Q1	$99M	Buy	712,954 +362,669	+104%	+$48.8M	0.68%	39
2022 Q4	$47.5M	Buy	+350,285	New	+$43.9M	0.34%	87

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AGF Management's AZN Position: Q2 2026 in Review

AGF Management reduced its AstraZeneca (AZN) stake by 14% in Q2 2026, selling an estimated $44.2K and leaving 1,387 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #647.

AGF Management first reported a position in AZN in Q4 2022 and has held it in 14 quarters since. The position peaked at $104M in Q3 2024. 1,501 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

AGF Management held 1,387 shares of AstraZeneca worth $263K as of Q2 2026.
AGF Management sold 235 AstraZeneca shares in Q2 2026, an estimated $44.2K.
AstraZeneca made up ﹤0.01% of AGF Management's portfolio in Q2 2026, its #647 holding.
AGF Management first reported a position in AstraZeneca in Q4 2022 and has held it in 14 quarters since.
AGF Management's AstraZeneca position peaked at $104M in Q3 2024.
1,501 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.